¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦1ȸ Çѱ¹°£¿Ü°ú¿¬±¸È¸ ¼¼¹Ì³ª : 2022-05-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦1ȸ Çѱ¹°£¿Ü°ú¿¬±¸È¸ ¼¼¹Ì³ª : 2022-05-21
±³À°ÀÏÀÚ : 2022-05-21
±³À°Àå¼Ò : ´ë¿õÁ¦¾à º£¾îȦ  
±³À°ÁÖÁ¦ : Á¦1ȸ Çѱ¹°£¿Ü°ú¿¬±¸È¸ ¼¼¹Ì³ª
ÁÖÃÖ±â°ü : Çѱ¹°£´ãÃé¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Çѱ¹°£¿Ü°ú¿¬±¸È¸  
´ã´çÀÚ : ±èÀºÈñ
¿¬¶ôó : 02-2135-2279  
À̸ÞÀÏ : office@thekalis.or.kr      
±³À°Á¾·ù : ¿Ü°ú      
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-21 º£¾î Ȧ 13:00~13:15 Indication setting for each approach for the beginner; Which approach should we use?  ÇÑ¿µ¼®(°æºÏÀÇ´ë) 
Åä·Ð 05-21 º£¾î Ȧ 13:15~13:30 ÁúÀÇÀÀ´ä  () 
±³À°½Ã°£ 05-21 º£¾î Ȧ 13:30~13:45 Each tip for glissonean pedicle approach in conventional and minimally invasive approach  ±èÁöÈÆ(±¹¸³¾Ï¼¾ÅÍ) 
Åä·Ð 05-21 º£¾î Ȧ 13:45~14:00 ÁúÀÇÀÀ´ä  () 
±³À°½Ã°£ 05-21 º£¾î Ȧ 14:00~14:15 The short-cut to shorten learning curve for liver surgery.  ÇÑ´ëÈÆ(¿¬¼¼ÀÇ´ë) 
Åä·Ð 05-21 º£¾î Ȧ 14:15~14:30 ÁúÀÇÀÀ´ä  () 
±³À°½Ã°£ 05-21 º£¾î Ȧ 14:30~15:00 Junior & Fellow ȸ¿ø ¼Ò°³  ÃÖ±âÈ«(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 15:00~16:00 Video presentation  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ05-21 º£¾î Ȧ 16:00~16:10   () 
±³À°½Ã°£ 05-21 º£¾î Ȧ 16:10~16:30 Current status of liver diseases including HCC in Korea  À¯¼öÁ¾(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 16:30~16:45 Working definition of resectable HCC?  ¹Ú¹Î¼ö(°æÈñÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 16:45~17:00 Recent updates of ablative therapies: RFA vs. MWA  À̹οì(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 17:00~17:15 TACE vs. Brigding TACE before Surgery  ¹Ú¿µ¸ñ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 17:15~17:30 Initial LT vs. Salvage LT  ÃÖ±Ô¼º(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 17:30~17:45 Role of adjuvant therapies after initial treatment for HCC  Á¶ÀºÁÖ(¼­¿ïÀÇ´ë) 
Åä·Ð 05-21 º£¾î Ȧ 17:45~18:00 Case discussion  ÃÖ¿µ·Ï(¼­¿ïÀÇ´ë) 
Åä·Ð 05-21 º£¾î Ȧ 18:00~18:10 ÁúÀÇÀÀ´ä  () 
±³À°½Ã°£ 05-21 º£¾î Ȧ 18:10~18:25 KOTUS-Liver ÀÚ·á ¼öÁý ÇöȲ ¹× °³¼±¹æ¾È  ÀÌÇØ¿ø(¼­¿ïÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦1ȸ Çѱ¹°£¿Ü°ú¿¬±¸È¸ ¼¼¹Ì³ª : 2022-05-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Çѱ¹ÀÇÇб³À°ÇÐȸ AME ±âº»ÀÇÇб³À° Á¦µµ¿Í Á¤Ã¥ : 2022-05-21
´ÙÀ½±Û 2022 ûÁÖ½ÃÀÇ»çȸ Ãá°è Çмú´ëȸ : 2022-05-21
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20478 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ(ÀÇ·áÀÎ) ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À° : 2024-05-09 0 91 2024-04-29
20477 ºÎ»ê ´ëÇÑ°£ÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Áý´ãȸ(°£¼¼Æ÷¾ÏÀÇ downstaging: Çö½Ç°ú ¹Ì·¡) : 2024-05-09 0 125 2024-04-29
20476 ÀÎõ Çѱ¹¿©ÀÚÀÇ»çȸ ÀÎõÁöȸ 5¿ù Çмú½ÉÆ÷Áö¾ö : 2024-05-09 0 89 2024-04-29
20475 Á¦ÁÖ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ Á¦ÁÖÁöȸ 5¿ù ¿¬¼ö°­Á : 2024-05-08 0 96 2024-04-29
20474 Á¦ÁÖ (3ÀÏÂ÷) 2024³â Á¦24Â÷ Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-04 0 109 2024-04-29
20473 Á¦ÁÖ (2ÀÏÂ÷) 2024³â Á¦24Â÷ Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-03 0 75 2024-04-29
20472 ÀüºÏ ´ëÇÑÇǺÎÁø±Õ ¹× °¨¿°ÇÐȸ ¼øȸ¿¬¼ö±³À° : 2024-05-03 0 94 2024-04-29
20471 Á¦ÁÖ (1ÀÏÂ÷) 2024³â Á¦24Â÷ Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-02 0 102 2024-04-29
20470 ´ë±¸ Á¦ 263Â÷ ´ëÇÑ ÇǺΰúÇÐȸ ´ë±¸°æºÏÁöºÎ Áý´ãȸ(¿øÇü Å»¸ð) : 2024-05-02 0 145 2024-04-29
20469 ±¤ÁÖ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ±¤ÁÖÀü³²Áöȸ Á¦51Â÷ ÇмúÁý´ãȸ : 2024-05-02 0 120 2024-04-29
20468 ºÎ»ê ´ëÇÑÀ忬±¸ÇÐȸ ºÎ¿ï°æÁöȸ Á¤±âÁý´ãȸ : 2024-04-29 0 110 2024-04-29
20467 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31 0 254 2024-04-17
20466 °æ±â ¾ÆÁִ뺴¿ø ÀÀ±ÞÀÇÇаú ¼³¸³ 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-05-30 0 194 2024-04-17
20465 ¼­¿ï Á¦20Â÷ ´ëÇѸð¹ßÇÐȸ Çмú´ëȸ ÇÁ·Î±×·¥ : 2024-05-26 0 160 2024-04-17
20464 °æ±â 2024³â Á¦86Â÷ ´ëÇÑ»ý½ÄÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-26 0 202 2024-04-17
41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷